Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 3Pancreatic Neoplasms 2Neoplasms 2Brain Neoplasms 2Prostatic Neoplasms 1Lymphoma 1Hypoxia 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Gemcitabine 358Fluorouracil 94Oxaliplatin 81Capecitabine 74130-nm albumin-bound paclitaxel 71Albumin-Bound Paclitaxel 70Radiotherapy 67Leucovorin 58Irinotecan 49Erlotinib Hydrochloride 47Cisplatin 44Bevacizumab 31pembrolizumab 30Radiosurgery 30Docetaxel 26Taxes 24Nivolumab 24Cetuximab 24Pancreaticoduodenectomy 20Drug Therapy 17folfirinox 16Cyclophosphamide 16Radiation 15Ipilimumab 13Endoscopic Ultrasound-Guided Fine Needle Aspiration 13Surgical Procedures, Operative 12Sorafenib 12Paclitaxel 12Neoadjuvant Therapy 12irinotecan sucrosofate 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Pancreatic Neoplasms × gadobutrol × Clear all
NCT01989000 2018-06-27

MIPA

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase NA Completed
47 enrolled
Gastrointestinal

Hypoxia, Pancreatic Neoplasms

NCT01995240 2017-03-20

REMP

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase NA Completed
23 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡